A study of sensitivity to anticancer agents in esophageal cancer
Matsumoto, N.
Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(1): 58-69
1986
ISSN/ISBN: 0003-9152 PMID: 2427048 Document Number: 279199
Document emailed within 1 workday
Related Documents
Nishiyama, M.; Noso, Y.; Yamaguchi, M.; Hirabayashi, N.; Toge, T.; Niimoto, M.; Hattori, T. 1986: Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 275-279Kikuchi, Y. 1994: Study of in vitro cancer sensitivity of anticancer drugs by Sdi (succinate dehydrogenase inhibition test) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2757-2762
Hagiwara, A.; Takahashi, T. 1987: A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents In Vivo 1(4): 241-252
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Imaizumi, M.; Li, Z.; Sakakibara, M.; Ojika, T.; Watanabe, H.; Nishimura, M.; Uchida, T.; Takeuchi, S.; Sugiyama, T.; Abe, T. 1994: Characteristics of the two newly established cell lines of human pulmonary adenocarcinoma and their sensitivity to anticancer agents Human Cell 7(1): 47-54
Fujiwara, K.; Kohno, I.; Tanaka, K.; Ogita, S.; Sasaki, Y.; Hirabayashi, K.; Yakushiji, M.; Tsunematsu, R.; Terashima, Y.; Taguchi, T.; Ohashi, Y.; Noda, K. 1999: Phase Ii dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group Anticancer Research 19(1b): 639-644
Fujita, F.; Fujita, M.; Inaba, H.; Sugimoto, T.; Okuyama, Y.; Taguchi, T. 1991: Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(13): 2263-2270
Iwagaki, H.; Fuchimoto, S.; Miyake, M.; Orita, K. 1988: Monitoring of the effect of anticancer drugs on the membrane potential and cytoplasmic free calcium ion mobilization in cancer cells as a drug sensitivity test Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2725-2730
Wang, G.-q.; Wei, W.-q.; Hao, C.-q.; Wang, G.-q.; Lü, N.; Qiao, Y.-l. 2010: A prospective study of the origin of esophageal squamous cell carcinoma in the esophageal mucosa:result from a high risk area of esophageal cancer in China during a 15-year follow up (1987 - 2002) Zhonghua Zhong Liu Za Zhi 32(3): 196-198
Dunn, S.E.; Hardman, R.A.; Kari, F.W.; Barrett, J.C. 1997: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs Cancer Research 57(13): 2687-2693
Shimoyama, S.; Konishi, T.; Kawahara, M.; Aoki, F.; Harada, N.; Shimizu, S.; Murakami, T.; Kaminishi, M. 1998: Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer Hepato-Gastroenterology 45(23): 1497-1504
Milano, G.ér. 2008: Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer La Revue du Praticien 58(10): 1056-1059
Kobayashi, K.; Takemoto, T.; Hino, M.; Hayashihara, K.; Nakahiro, K.; Wasai, S.; Niitani, H. 1992: Estimating doses of anti-cancer agents in sensitivity tests in vitro Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(3): 399-403
Takeuchi, S.; Akahoshi, Y.; Kasai, C.; Nishimoto, Y. 1984: Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors Gan no Rinsho. Japan Journal of Cancer Clinics 30(9 Suppl): 1113-1122
Sherishorina, S.I.; Solodova, T.L. 1970: A comparative study of the sensitivity of the agents of acute bacterial pneumonia to preparations of the nitrofuran series Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 47(5): 118-122
Ohtsu, T.; Sasaki, Y. 1993: Pharmacodynamics of anticancer agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(12): 1741-1749
Von Hoff, D.D.; Rozencweig, M.; Piccart, M. 1982: The cardiotoxicity of anticancer agents Seminars in Oncology 9(1): 23-33
Eckardt, J.; Eckhardt, G.; Villalona-Calero, M.; Drengler, R.; Von Hoff, D. 1995: New anticancer agents in clinical development Oncology 9(12): 1321-1328; 1331; Discussion: 1332-1334
Machoń, Z.; Wieczorek, J.; Mordarski, M. 1987: Isothiazolopyrimidines--new group of anticancer agents. i Archivum Immunologiae et Therapiae Experimentalis 35(5): 599-607
Andoh, T.; Okada, K. 1989: DNA topoisomerases and resistance to anticancer agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 2): 569-575